TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

July 27, 2024 00:20:23
Episode Cover

What Oxygenation Strategy Should We Use for COVID-19 Patients?

Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation...

Listen

Episode 0

May 10, 2021 00:39:02
Episode Cover

Early ED Sepsis Care

Over 80% of patients with sepsis receive care in the ED.  Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies...

Listen

Episode 0

July 02, 2020 00:46:15
Episode Cover

Updates in the Critical Care Management of COVID-19 Patients

There has been an explosion of literature on the evaluation and management of patients with COVID-19 infection.  In this podcast, we discuss updates (as...

Listen